| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Clinical Services | Chief Operating Officer
1 company
Shovlin Robert J. is a President, Clinical Services at NEOGENOMICS INC. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2021 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 130,604 | $39.31 | $5,134,043.24 | -46.5% | +13.9% | -79.9% | |
| Jul 30, 2020 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 81,356 | $38.17 | $3,105,358.52 | -35.4% | - | - | |
| Mar 4, 2020 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 98,093 | $30.86 | $3,027,149.98 | -39.3% | - | - | |
| Nov 1, 2019 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 106,274 | $22.99 | $2,442,745.77 | -24.5% | - | - | |
| May 2, 2019 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 119,347 | $22.14 | $2,642,342.58 | -23.4% | - | - | |
| Feb 27, 2019 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 186,014 | $18.96 | $3,527,391.57 | -39.0% | - | - | |
| Nov 12, 2018 | NEO Neogenomics Inc | President, Clinical Services | Sale+OE | 216,493 | $17.00 | $3,680,622.68 | -43.3% | - | - | |
| Jun 29, 2018 | NEO Neogenomics Inc | President, Clinical Services | Sell | 12,941 | $13.12 | $169,785.92 | -24.5% | - | - | |
| Dec 3, 2015 | NEO Neogenomics Inc | Chief Operating Officer | Buy | 6,550 | $7.75 | $50,762.50 | New | - | - |